Dr. Brewer joined the University of Chicago in February 2018. From 2011-2017, he served as Director of the HIV/STI Portfolio at the Louisiana Public Health Institute in New Orleans. His research and intervention efforts are focused on understanding and eliminating the socio-structural barriers to HIV services among young Black men who have sex with men (YBMSM), persons living with HIV infection (PLWH), and criminal justice-involved populations in Chicago and the Southern United States.

Sumit Chanda earned his Ph.D. from Stanford University in 2001, and received his post-doctoral training at the Genomics Institute of the Novartis Research Foundation (GNF). He subsequently transitioned to a Group Leader position, and established his research group in the Division of Cellular Genomics at GNF. In 2007, he joined the Infectious and Inflammatory Disease Center at Sanford-Burnham Medical Research Institute as an Associate Professor. Dr. Chanda also holds an Adjunct Professor appointment at the Salk Institute for Biological Studies, as well as a Visiting Scientist position at the Genomics Institute of the Novartis Research Foundation.

Jennifer Jao, MD, MPH
Associate Professor
Department of Pediatrics, Division of Infectious Diseases
Department of Medicine, Division of Infectious Diseases
Northwestern University Feinberg School of Medicine

Dual certified in Internal Medicine and Pediatrics, Dr. Jao is an Associate Professor at the Northwestern University Feinberg School of Medicine in the Departments of Pediatric and Adult Infectious Diseases whose research focus is HIV maternal child health. She obtained her BA in French Literature at Tulane University and MD at the Medical College of Georgia. She went on to complete a Medicine/Pediatrics residency at Rush University Medical Center in Chicago and her Infectious Disease Fellowship along with her MPH degree at the Icahn School of Medicine at Mount Sinai. Dr. Jao has led cohorts of HIV-infected pregnant women and their children both in the U.S. and Africa, and as a translational researcher, her research portfolio targets the long-term metabolic effects of in utero exposure to HIV and antiretroviral medications. She is the Principal Investigator on NIH-funded studies in the U.S. and Africa to better understand the long-term health outcomes of HIV-exposed infants. She is a member of the U.S. Panel on the Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission Guidelines Panel and the Scientific Leadership Group of the Pediatric HIV/AIDS Cohort Study (PHACS).